A randomized, single-blind study of lansoprazole for the prevention of exacerbations of chronic obstructive pulmonary disease in older patients

Journal of the American Geriatrics Society

Volumn 57, Issue 8, 2009, Pages 1453-1457

  Sasaki, Takahiko ^a,b   Nakayama, Katsutoshi ^a,c   Yasuda, Hiroyasu ^a,b   Yoshida, Motoki ^a   Asamura, Takaaki ^a   Ohrui, Takashi ^a   Arai, Hiroyuki ^a   Araya, Jun ^c   Kuwano, Kazuyoshi ^c   Yamaya, Mutsuo ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chronic obstructive pulmonary disease; Common cold; Exacerbation; Lower airway infection; Proton pump inhibitor

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; LANSOPRAZOLE; THEOPHYLLINE;

ADD ON THERAPY; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; COMMON COLD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE EXACERBATION; DRUG MECHANISM; DRUG WITHDRAWAL; FEMALE; GERIATRIC PATIENT; HUMAN; HUMAN RHINOVIRUS; JAPAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; RISK REDUCTION; SINGLE BLIND PROCEDURE; SMOKING CESSATION; TREATMENT DURATION;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; AGED; ANTI-INFECTIVE AGENTS; COMMON COLD; FEMALE; HUMANS; JAPAN; LOGISTIC MODELS; MALE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 68149152912     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2009.02349.x     Document Type: Article

References (25)

1. Smith CB, Golden CA, Kanner RE et al. Association of viral and Mycoplasma pneumoniae infections with acute respiratory illness in patients with chronic obstructive pulmonary diseases. Am Rev Respir Dis 1980 121 : 225 232.
2. Stenhouse AC. Rhinovirus infection in acute exacerbation of chronic bronchitis: A controlled prospective study. BMJ 1967 3 : 461 463.
3. Ncnamara MJ, Philips IA, Williams OB. Viral and Mycoplasma pneumoniae infections in exacerbations of chronic lung disease. Am Rev Respir Dis 1969 100 : 19 24.
4. Monto AS, Higgins MW, Ross HW. An epidemiologic study revealed that patients with COPD experienced more acute lower respiratory illness rates were higher as well. The Tecumseh study of respiratory illness: VIII. Acute infection in chronic respiratory disease and comparison groups. Am Rev Respir Dis 1975 111 : 27 36.
5. Greve JM, Davis G, Meyer AM et al. The major human rhinovirus receptor is ICAM-1. Cell 1989 56 : 839 847.
6. Casasnovas JM, Springer TA. Pathway of rhinovirus disruption by soluble intercellular adhesion molecule 1 (ICAM-1): An intermediate in which ICAM-1 is bound and RNA is released. J Virol 1994 68 : 5882 5889.
7. Sasaki T, Yamaya M, Yasuda H et al. The proton pump inhibitor lansoprazole inhibits rhinovirus infection in cultured human tracheal epithelial cells. Eur J Pharmacol 2005 509 : 201 210.
8. Ohara T, Arakawa T. Lansoprazole decreases peripheral blood monocytes and intercellular adhesion molecule-1-positive mononuclear cells. Dig Dis Sci 1999 44 : 1710 1715.
9. Watanabe T, Higuchi K, Tominaga K et al. Acid regulates inflammatory response in a rat model of induction of gastric ulcer recurrence by interleukin 1 beta. Gut 2001 48 : 743 747.
10. +-ATPases of renal cortical and medullary endosomes are differentially sensitive to Sch-2080 and omeprazole. Am J Physiol 1994 266 : F868 F877.
11. Kountouras J, Boura P, Lygidakis NJ. Omeprazole and regulation of cytokine profile in Helicobacter pylori-infected patients with duodenal ulcer disease. Hepatogastroenterology 2000 47 : 1301 1304.
12. Global Initiative for Chronic Obstructive Lung Disease. 2004 Update : Workshop Report, Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease [on-line]. Available at Accessed on October 15, 2005.
13. Carlsson R, Dent J, Bennett JR et al. Endoscopic assessment of oesophagitis: Clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999 45 : 172 180.
14. Jackson GG, Dowling HF, Spiesman IG et al. Transmission of the common cold to volunteers under controlled conditions: I. The common cold as a clinical entry. Arch Intern Med 1958 101 : 267 278.
15. Rodrigues-Roisin R. Toward a consensus definition for COPD exacerbations. Chest 2000 117 : 398S 401S.
16. Suzuki T, Yanai M, Yamaya M et al. Erythromycin and common cold in COPD. Chest 2001 120 : 730 733.
17. Yasuda H, Yamaya M, Sasaki T et al. Carbocisteine reduces frequency of common colds and exacerbations in patients with chronic obstructive pulmonary disease. J Am Geriatr Soc 2006 54 : 378 380.
18. Mallia P, Johnston SL. How viral infections cause exacerbation of airway diseases. Chest 2006 130 : 1203 1210.
19. Gern JE, Busse WW. Association of rhinovirus infections with asthma. Clin Microbiol Rev 1999 12 : 9 18.
20. D'Urzo A, Jugovic P. Chronic cough. Three most common causes. Can Fam Physician 2002 48 : 1311 1316.
21. Harding SM. Recent clinical investigations examining the association of asthma and gastroesophageal reflux. Am J Med 2003 115 (Suppl 3A) : 39S 44S.
22. García Rodríguez LA, Ruigmez A, Martín-Merino E et al. Relationship between gastroesophageal reflux disease and COPD in UK primary care. Chest 2008 134 : 1223 1230.
23. Rascon-Aguilar IE, Pamer M, Wludyka P et al. Role of Gastroesophageal Reflux symptoms in exacerbations of COPD. Chest 2006 130 : 1096 1101.
24. Terada K, Muro S, Sato S et al. Impact of gastro-oesophageal reflux disease symptoms on COPD exacerbation. Thorax 2008 63 : 951 955.
25. Geppetti P, Materazzi S, Nicoletti P. The transient receptor potential vanilloid 1: Role in airway inflammation and disease. Eur J Pharmacol 2006 533 : 207 214.